Malignant melanoma of the uterine cervix: A case report

Journal of Obstetrics and Gynaecology Research

Volumn 23, Issue 6, 1997, Pages 511-519

  Miyagi, Yasunari ^a   Yamada, Shinako ^a   Miyagi, Yuji ^a   Yamamoto, Junko ^a   Kawanishi, Kunihiro ^a   Yoshinouchi, Mitsuo ^a   Kodama, Junichi ^a   Kamimura, Shigehito ^a   Takamoto, Norio ^a   Kudo, Takafumi ^a   Taguchi, Kohji ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Malignant melanoma; MRI; MTS1 CDK4I; Uterine cervix

Indexed keywords

CISPLATIN; CYCLINE; DACARBAZINE; GADOLINIUM PENTETATE; MELANIN; NIMUSTINE; VINCRISTINE SULFATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; ELECTRON MICROSCOPY; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 0031451426     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1997.tb00880.x     Document Type: Article

References (15)

1. Curtin JP, Morrow CP. Melanoma of female genital tract. In: Coppleson M ed. Gynecologic Oncology. New York: Churchill Livingstone, 1992; 2: 1059-1068
2. Cid JM. La pigmentation melanique de l'endocervix. Ann Anat Pathol 1959; 4: 617-628
3. Kristiansen SB, Anderson R, Cohen DM. Primary malignant melanoma of the cervix and review of the literature. Gynecol Oncol 1992; 47: 398-403
4. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756
5. Kamb A, Gruis, NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III; Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440
6. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC. Germline p16 mutations in familial melanoma. Nature Genet 1994; 8: 15-21
7. Kamb A, Shattuck-Eidens D, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994; 8: 22-26
8. Ohashi H, Nagano M. A primary malignant melanoma of the cervix uteri. J Jpn Soc Cancer Ther 1979; 14: 138-142
9. Uehara T, Takayama S, Takemura T, Kasuga T. Foci of stromal melanocytes (so-called blue naevus) of the uterine cervix in Japanese women. Virchows Archiv A Pathlog Anat 1991; 418: 327-331
10. Yamada T, Itou U, Watanabe Y, Ohashi S. Cytologic diagnosis of malignant melanoma. Acta Cytol 1972; 16: 70-76
11. Yamada T, Honma K, Takagi M. Cytomorphologic analysis on 25 malignant melanomas. J Jpn Soc Cytol 1982; 21: 503-509
12. Hamatani J, Ooya Y, Uchida K, Sugita M, Sugishita T, Tenjin Y. A case of primary malignant melanoma of the uterine cervix. J Jpn Soc Cytol 1990; 29: 59-63
13. McGovern VJ, Murad TM. Pathology of melanoma. In: Balch CM, Milton GW, eds. Cutaneous melanoma. Philadelphia: Lippincott, 1985; 29-53
14. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-726
15. Mulder NH, Sleijfer DTh, de Vries EGE, Schraffordt Koops H, Willemse PHB. Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma. J Cancer Res Clin Oncol 1990; 116: 301-302